JINCY SAJAN: Open Payments
NPI 1710644851 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 21 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $2,611 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 9 | $152 |
| 180 Medical, Inc. | 3 | $66 |
| ABBVIE INC. | 3 | $50 |
| PFIZER INC. | 1 | $29 |
| Procept Biorobotics Corporation | 1 | $27 |
| Laborie Medical Technologies Corp. | 2 | $25 |
| Janssen Biotech, Inc. | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
Products named: GEMTESA, LUPRON DEPOT, XTANDI, AQUABEAM ROBOTIC SYSTEM, GENTLECATH, Optilume BPH Drug Coated Balloon Catheter, ERLEADA, Exparel.
Industry payments across TX — which companies pay providers there.
